LAKE NONA, Fla. , Oct. 28, 2024 /PRNewswire/ -- Fountain Life, a company that offers longevity, preventative health, advanced diagnostics, and therapeutics, today announced that it has developed Zora AI, the world's first generative AI platform specially trained in functional and longevity medicine, and a further differentiator of Fountain Life among longevity and healthcare companies.
Fountain Life's Zora AI is powering two generative AI "co-pilots:" one for Fountain Life's clinical staff to consult as an expert reference on functional medicine protocols and latest research, and another for Fountain Life APEX members to answer their questions about their in-depth diagnostic test results and health optimization plan and get functional health-oriented perspectives on more general health questions. The member co-pilot is accessible through Fountain Life's smartphone app through either text- or voice-based interactions. Members can ask Zora any health-related questions and receive "everyday English" responses tailored to their unique, comprehensive health profile, including their unique genetic makeup, diagnostic test results, images, family history, and more, combined with the latest research in functional medicine and longevity.
"With scores of research papers being generated monthly, Zora AI offers the extraordinary potential to keep our clinical staff at the leading edge of functional and longevity medicine research with ease and efficiency," said Dr. Bill Kapp , MD, CEO of .